Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10664)
All Articles published online
|
Publishing Process of This Article
|
Oct 26, 2015 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dragu DL, Necula LG, Bleotu C, Diaconu CC, Chivu-Economescu M. Therapies targeting cancer stem cells: Current trends and future challenges. World J Stem Cells 2015; 7(9): 1185-1201 [PMID: 26516409 DOI: 10.4252/wjsc.v7.i9.1185] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v7/i9/1185.htm |
| Number | Citing Articles |
| 1 |
Belay Zeleke Sibuh, Rekha Gahtori, Noura Al-Dayan, Kumud Pant, Bahareh Farasati Far, Asrar Ahmad Malik, Ashish Kumar Gupta, Soumi Sadhu, Sushil Dohare, Piyush Kumar Gupta. Emerging trends in immunotoxin targeting cancer stem cells. Toxicology in Vitro 2022; 83: 105417 doi: 10.1016/j.tiv.2022.105417
|
| 2 |
Ming-li Han, Fang Wang, Yuan-ting Gu, Xin-hong Pei, Xin Ge, Guang-cheng Guo, Lin Li, Xin Duan, Ming-Zhi Zhu, Yi-meng Wang. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG. Biomedicine & Pharmacotherapy 2016; 80: 304 doi: 10.1016/j.biopha.2016.03.024
|
| 3 |
Ahmed Maklad, Anjana Sharma, Iman Azimi. Calcium Signaling in Brain Cancers: Roles and Therapeutic Targeting. Cancers 2019; 11(2): 145 doi: 10.3390/cancers11020145
|
| 4 |
Bruna Corradetti, Salvatore Vaiasicca, Mauro Mantovani, Edy Virgili, Massimo Bonucci, Ivano Hammarberg Ferri. Bioactive Immunomodulatory Compounds: A Novel Combinatorial Strategy for Integrated Medicine in Oncology? BAIC Exposure in Cancer Cells. Integrative Cancer Therapies 2019; 18 doi: 10.1177/1534735419866908
|
| 5 |
Yan‐Bo Zheng, Jian‐Hua Gong, Xiu‐Jun Liu, Yi Li, Yong‐Su Zhen. A CD13‐targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis. Molecular Carcinogenesis 2017; 56(5): 1395 doi: 10.1002/mc.22600
|
| 6 |
Sudhan Debnath, Manupati Kanakaraju, Minarul Islam, Ragini Yeeravalli, Debanjan Sen, Amitava Das. In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents. Computational Biology and Chemistry 2019; 83: 107156 doi: 10.1016/j.compbiolchem.2019.107156
|
| 7 |
Heejin Lee, Jun Woo Kim, Dae Kyung Kim, Dong Kyu Choi, Seul Lee, Ji Hoon Yu, Oh-Bin Kwon, Jungsul Lee, Dong-Seok Lee, Jae Ho Kim, Sang-Hyun Min. Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells. International Journal of Molecular Sciences 2020; 21(7): 2327 doi: 10.3390/ijms21072327
|
| 8 |
Monika A. Papież, Wirginia Krzyściak. Biological Therapies in the Treatment of Cancer—Update and New Directions. International Journal of Molecular Sciences 2021; 22(21): 11694 doi: 10.3390/ijms222111694
|
| 9 |
James E. Trosko. Cancer Prevention and Therapy of Two Types of Gap Junctional Intercellular Communication–Deficient “Cancer Stem Cell”. Cancers 2019; 11(1): 87 doi: 10.3390/cancers11010087
|
| 10 |
Seamus Balinth, Matthew L. Fisher, Yon Hwangbo, Caizhi Wu, Carlos Ballon, Xueqin Sun, Alea A. Mills. EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma. Oncogene 2022; 41(35): 4130 doi: 10.1038/s41388-022-02417-4
|
| 11 |
Ellen M Caparosa, Jonathan Stem, Adam E Snook, Scott A Waldman. Biomarker Targeting of Colorectal Cancer Stem Cells. Biomarkers in Medicine 2019; 13(11): 891 doi: 10.2217/bmm-2019-0227
|
| 12 |
Yelei Guo, Kaichao Feng, Yao Wang, Weidong Han. Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment. Protein & Cell 2018; 9(6): 516 doi: 10.1007/s13238-017-0394-6
|
| 13 |
Jin Sook Suh, Hyun Jung Lee, Hyun Nam, Beom Soo Jo, Dong Woo Lee, Ji-Hye Kim, Jue Yeon Lee, Chong Pyoung Chung, Gene Lee, Yoon Jeong Park. Control of cancer stem cell like population by intracellular target identification followed by the treatment with peptide-siRNA complex. Biochemical and Biophysical Research Communications 2017; 491(3): 827 doi: 10.1016/j.bbrc.2017.05.148
|
| 14 |
Farzaneh Sharifzad, Saeid Ghavami, Javad Verdi, Soura Mardpour, Mahsa Mollapour Sisakht, Zahra Azizi, Adeleh Taghikhani, Marek J. Łos, Esmail Fakharian, Marzieh Ebrahimi, Amir Ali Hamidieh. Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resistance Updates 2019; 42: 35 doi: 10.1016/j.drup.2018.03.003
|
| 15 |
Reza Bayat Mokhtari, Narges Baluch, Micky Ka Hon Tsui, Sushil Kumar, Tina S. Homayouni, Karen Aitken, Bikul Das, Sylvain Baruchel, Herman Yeger. Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3126-7
|
| 16 |
Jiangang Zhao, Jiahui Li, Hans A. Schlößer, Felix Popp, Marie Christine Popp, Hakan Alakus, Karl-Walter Jauch, Christiane J. Bruns, Yue Zhao. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer. Stem Cells International 2017; 2017: 1 doi: 10.1155/2017/6012810
|
| 17 |
Partha Biswas, Dipta Dey, Polash Kumar Biswas, Tanjim Ishraq Rahaman, Shuvo Saha, Anwar Parvez, Dhrubo Ahmed Khan, Nusrat Jahan Lily, Konka Saha, Md Sohel, Mohammad Mehedi Hasan, Salauddin Al Azad, Shabana Bibi, Md. Nazmul Hasan, Mohammed Rahmatullah, Jaemoo Chun, Md. Ataur Rahman, Bonglee Kim. A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells. International Journal of Molecular Sciences 2022; 23(19): 11746 doi: 10.3390/ijms231911746
|
| 18 |
Micol E Fiori, Lidia Villanova, Ruggero De Maria. Cancer stem cells: at the forefront of personalized medicine and immunotherapy. Current Opinion in Pharmacology 2017; 35: 1 doi: 10.1016/j.coph.2017.04.006
|
| 19 |
Charli Dominguez, Kwong-Yok Tsang, Claudia Palena. Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies. Cell Death & Disease 2016; 7(9): e2380 doi: 10.1038/cddis.2016.297
|
| 20 |
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi, G.J. Peters. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology 2017; 44: 43 doi: 10.1016/j.semcancer.2017.04.006
|
| 21 |
Hua Cheng, Liyan Bai, Xi Zhang, Wenfei Chen, Simin He, Yunqi Liu, Juan Wang, Shaoli Song. 68Ga labeled Olmutinib: Design, synthesis, and evaluation of a novel PET EGFR probe. Bioorganic Chemistry 2024; 153: 107987 doi: 10.1016/j.bioorg.2024.107987
|
| 22 |
Victoria M. Prince, Silvana Papagerakis, Mark E. Prince. Oral Cancer and Cancer Stem Cells: Relevance to Oral Cancer Risk Factors, Premalignant Lesions, and Treatment. Current Oral Health Reports 2016; 3(2): 65 doi: 10.1007/s40496-016-0081-3
|
| 23 |
Raheleh Roudi, Marzieh Ebrahimi, Ahmad Shariftabrizi, Zahra Madjd. Cancer stem cell research in Iran: potentials and challenges. Future Oncology 2017; 13(20): 1809 doi: 10.2217/fon-2017-0091
|
| 24 |
Pinaki S. Nakod, Yonghyun Kim, Shreyas S. Rao. Biomimetic models to examine microenvironmental regulation of glioblastoma stem cells. Cancer Letters 2018; 429: 41 doi: 10.1016/j.canlet.2018.05.007
|
| 25 |
Hamed Rezayatmand, Mahboobeh Razmkhah, Iman Razeghian-Jahromi. Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02856-6
|
| 26 |
Amirhossein Izadpanah, Niloufar Mohammadkhani, Mina Masoudnia, Mahsa Ghasemzad, Arefeh Saeedian, Hamid Mehdizadeh, Mansour Poorebrahim, Marzieh Ebrahimi. Update on immune‐based therapy strategies targeting cancer stem cells. Cancer Medicine 2023; 12(18): 18960 doi: 10.1002/cam4.6520
|
| 27 |
Yasaman Mohammadi, Seyed Mohammad Tavangar, Massoud Saidijam, Razieh Amini, Katayoon Etemadi, Fatemeh Karimi Dermani, Rezvan Najafi. DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c. Biomedicine & Pharmacotherapy 2018; 103: 301 doi: 10.1016/j.biopha.2018.04.042
|
| 28 |
Ibrahim O Alanazi, Zahid Khan. Understanding EGFR Signaling in Breast Cancer and Breast Cancer Stem Cells: Overexpression and Therapeutic Implications. Asian Pacific Journal of Cancer Prevention 2016; 17(2): 445 doi: 10.7314/APJCP.2016.17.2.445
|
| 29 |
Piyush Kumar Gupta, Gunasekaran Dharanivasan, Ranjita Misra, Santosh Gupta, Rama Shanker Verma. NanoBioMedicine. 2020; : 67 doi: 10.1007/978-981-32-9898-9_4
|
| 30 |
Debabrata G Dastidar, Amlan Das, Satabdi Datta, Suvranil Ghosh, Mahadeb Pal, Neeraj S Thakur, Uttam C Banerjee, Gopal Chakrabarti. Paclitaxel-Encapsulated Core–Shell Nanoparticle of Cetyl Alcohol for Active Targeted Delivery Through Oral Route. Nanomedicine 2019; 14(16): 2121 doi: 10.2217/nnm-2018-0419
|
| 31 |
Mohinder Pal Bansal. Redox Regulation and Therapeutic Approaches in Cancer. 2023; : 311 doi: 10.1007/978-981-99-7342-2_9
|
| 32 |
Ana S. Nunes, Andreia S. Barros, Elisabete C. Costa, André F. Moreira, Ilídio J. Correia. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnology and Bioengineering 2019; 116(1): 206 doi: 10.1002/bit.26845
|
| 33 |
Yong Sun Lee, Chung Hee Lee, Jun Tae Bae, Kyung Tak Nam, Dae Bong Moon, Ok Kyung Hwang, Jeong Soon Choi, Tae Hoon Kim, Hyoung Ok Jun, Young Suk Jung, Dae Yeon Hwang, Sang-Bae Han, Do Young Yoon, Jin Tae Hong. Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0943-8
|
| 34 |
Shivang Dhoundiyal, Md Aftab Alam. Advancements in Biotechnology and Stem Cell Therapies for Breast Cancer Patients. Current Stem Cell Research & Therapy 2024; 19(8): 1072 doi: 10.2174/011574888X268109230924233850
|
| 35 |
Prashant S. Kharkar. Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015). Expert Opinion on Therapeutic Patents 2017; 27(7): 753 doi: 10.1080/13543776.2017.1325465
|
| 36 |
Marcel Henrique Marcondes Sari, Luana Mota Ferreira, Letícia Cruz. The use of natural gums to produce nano-based hydrogels and films for topical application. International Journal of Pharmaceutics 2022; 626: 122166 doi: 10.1016/j.ijpharm.2022.122166
|
| 37 |
Keighley N. Reisenauer, Jaquelin Aroujo, Yongfeng Tao, Santhalakshmi Ranganathan, Daniel Romo, Joseph H. Taube. Therapeutic vulnerabilities of cancer stem cells and effects of natural products. Natural Product Reports 2023; 40(8): 1432 doi: 10.1039/D3NP00002H
|
| 38 |
Kwang Woon Kim, Julia Y. Kim, Jingbo Qiao, Rachael A. Clark, Camille M. Powers, Hernan Correa, Dai H. Chung. Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma. Oncotarget 2019; 10(54): 5645 doi: 10.18632/oncotarget.27210
|
| 39 |
Reza Moazamiyanfar, Sepideh Rezaei, Hasan AliAshrafzadeh, Nima Rastegar-Pouyani, Emad Jafarzadeh, Kave Mouludi, Ehsan Khodamoradi, Mohsen Zhaleh, Shahram Taeb, Masoud Najafi. Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives. Current Pharmaceutical Design 2023; 29(22): 1713 doi: 10.2174/1381612829666230426115424
|
| 40 |
Arijit Chakraborty, Soma Ghosh, Bratisha Biswas, Sreemanta Pramanik, Jerome Nriagu, Subhamoy Bhowmick. Epigenetic modifications from arsenic exposure: A comprehensive review. Science of The Total Environment 2022; 810: 151218 doi: 10.1016/j.scitotenv.2021.151218
|
| 41 |
Christine Altmann, Stefanie Keller, Mirko H. H. Schmidt. The Role of SVZ Stem Cells in Glioblastoma. Cancers 2019; 11(4): 448 doi: 10.3390/cancers11040448
|
| 42 |
Asmaa Reda, Salma Hosseiny, Ibrahim M El-Sherbiny. Next-generation Nanotheranostics Targeting Cancer Stem Cells. Nanomedicine 2019; 14(18): 2487 doi: 10.2217/nnm-2018-0443
|
| 43 |
Clarence Ching Huat Ko, Wai Kit Chia, Gayathri Thevi Selvarajah, Yoke Kqueen Cheah, Yin Ping Wong, Geok Chin Tan. The Role of Breast Cancer Stem Cell-Related Biomarkers as Prognostic Factors. Diagnostics 2020; 10(9): 721 doi: 10.3390/diagnostics10090721
|
| 44 |
Agata Olejniczak, Magdalena Szaryńska, Zbigniew Kmieć. In vitro characterization of spheres derived from colorectal cancer cell lines. International Journal of Oncology 2017; doi: 10.3892/ijo.2017.4206
|
| 45 |
Fatemeh Khatami, Maryam Aghaii, Fatemeh Dadkhah Tehrani. Stem Cells in Urology. 2020; : 15 doi: 10.1007/978-3-030-41476-4_3
|
| 46 |
Anna De Blasio, Renza Vento, Riccardo Di Fiore. Mcl‐1 targeting could be an intriguing perspective to cure cancer. Journal of Cellular Physiology 2018; 233(11): 8482 doi: 10.1002/jcp.26786
|
| 47 |
Daniele Fanale, Nadia Barraco, Angela Listì, Viviana Bazan, Antonio Russo. Non-coding RNAs in Colorectal Cancer. Advances in Experimental Medicine and Biology 2016; 937: 93 doi: 10.1007/978-3-319-42059-2_5
|
| 48 |
Xiaoyue Cui, Rui Liu, Lian Duan, Dan Cao, Qiaoling Zhang, Aijie Zhang. CAR‐T therapy: Prospects in targeting cancer stem cells. Journal of Cellular and Molecular Medicine 2021; 25(21): 9891 doi: 10.1111/jcmm.16939
|
| 49 |
Benjamin Bonavida. Cancer Stem Cell Resistance to Targeted Therapy. Resistance to Targeted Anti-Cancer Therapeutics 2019; 19: 93 doi: 10.1007/978-3-030-16624-3_4
|
| 50 |
Shiwani Limbu, Kara E. McCloskey, Hyun-Sung Lee. Stemness genes and miR-1247-3p expression associate with clinicopathological parameters and prognosis in lung adenocarcinoma. PLOS ONE 2023; 18(11): e0294171 doi: 10.1371/journal.pone.0294171
|
| 51 |
Jesse A. Stoff. Selected Office Based Anticancer Treatment Strategies. Journal of Oncology 2019; 2019: 1 doi: 10.1155/2019/7462513
|
| 52 |
Lyudmila Ounpuu, Aleksandr Klepinin, Martin Pook, Indrek Teino, Nadezda Peet, Kalju Paju, Kersti Tepp, Vladimir Chekulayev, Igor Shevchuk, Sulev Koks, Toivo Maimets, Tuuli Kaambre. 2102Ep embryonal carcinoma cells have compromised respiration and shifted bioenergetic profile distinct from H9 human embryonic stem cells. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(8): 2146 doi: 10.1016/j.bbagen.2017.05.020
|
| 53 |
Efraín A Cermeño, Meghan J O’Melia, Woojin M Han, Austin Veith, Graham Barber, Emina H Huang, Susan N Thomas, Andrés J García. Hydrodynamic shear-based purification of cancer cells with enhanced tumorigenic potential. Integrative Biology 2020; 12(1): 1 doi: 10.1093/intbio/zyz038
|
| 54 |
Saskia Klutzny, Anna Anurin, Barbara Nicke, Joseph L. Regan, Martin Lange, Luise Schulze, Karsten Parczyk, Patrick Steigemann. PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0202-5
|
| 55 |
Javier Campos, Manuel Varas-Godoy, Ziyad Samir Haidar. Physicochemical Characterization of chitosan-hyaluronan-coated Solid Lipid Nanoparticles for the Targeted Delivery of Paclitaxel: a proof-of-concept Study in Breast Cancer Cells. Nanomedicine 2017; 12(5): 473 doi: 10.2217/nnm-2016-0371
|
| 56 |
Amar Desai, Yan Yan, Stanton L. Gerson. Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical Success. Stem Cells Translational Medicine 2019; 8(1): 75 doi: 10.1002/sctm.18-0123
|
| 57 |
Claudia Peitzsch, Anna Tyutyunnykova, Klaus Pantel, Anna Dubrovska. Cancer stem cells: The root of tumor recurrence and metastases. Seminars in Cancer Biology 2017; 44: 10 doi: 10.1016/j.semcancer.2017.02.011
|
| 58 |
Anbok Lee, Kyu Yeoun Won, Sung-Jig Lim, Sun Young Cho, Sang-Ah Han, SaeGwang Park, Jeong-Yoon Song. ALDH1 and tumor infiltrating lymphocytes as predictors for neoadjuvant chemotherapy response in breast cancer. Pathology - Research and Practice 2018; 214(5): 619 doi: 10.1016/j.prp.2018.04.006
|
| 59 |
Zuhal Gucin, Nur Buyukpinarbasili, MelinOzgun Gecer, YelizEmine Ersoy, HaciMehmet Turk, Seyma Yildiz, DirencOzlem Aksoy. Stem cell markers: A guide to neoadjuvant therapy in breast carcinomas. Indian Journal of Pathology and Microbiology 2023; 66(3): 495 doi: 10.4103/ijpm.ijpm_1274_21
|
| 60 |
Jennifer Harrington, Louise Carter, Bristi Basu, Natalie Cook. Drug development and clinical trial design in pancreatico-biliary malignancies. Current Problems in Cancer 2018; 42(1): 73 doi: 10.1016/j.currproblcancer.2018.01.003
|
| 61 |
Guangzhi Wang, Jia Shen, Jiahang Sun, Zhenfeng Jiang, Jiabing Fan, Hongjun Wang, Shan Yu, Yu Long, Yi Liu, Hongbo Bao, Kelvin Xi Zhang, Ke Han, Minwei Zhu, Yongri Zheng, Zhiguo Lin, Chuanlu Jiang, Mian Guo. Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/β-Catenin Signaling. Clinical Cancer Research 2017; 23(21): 6640 doi: 10.1158/1078-0432.CCR-17-0774
|
| 62 |
Brittanie Partridge, John H. Rossmeisl, Alexandra M. Kaloss, Erwin Kristobal Gudenschwager Basso, Michelle H. Theus. Novel ablation methods for treatment of gliomas. Journal of Neuroscience Methods 2020; 336: 108630 doi: 10.1016/j.jneumeth.2020.108630
|
| 63 |
Teruaki Takasaki, Kanako Hagihara, Ryosuke Satoh, Reiko Sugiura, Jaeseok Han. More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/4397159
|
| 64 |
Ching-Feng Chiu, Jonathan Jaime G. Guerrero, Ric Ryan H. Regalado, Ma. Joy B. Zamora, Jiayan Zhou, Kin Israel Notarte, Yu-Wei Lu, Paolo C. Encarnacion, Cidne Danielle D. Carles, Edrian M. Octavo, Dan Christopher I. Limbaroc, Charupong Saengboonmee, Shih-Yi Huang. Insights into Metabolic Reprogramming in Tumor Evolution and Therapy. Cancers 2024; 16(20): 3513 doi: 10.3390/cancers16203513
|
| 65 |
Martina Gatzka. Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies. Cancers 2018; 10(6): 155 doi: 10.3390/cancers10060155
|
| 66 |
Karolina Małgorzata Kapturska, Aleksandra Pawlak. New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine. Veterinary and Comparative Oncology 2023; 21(3): 357 doi: 10.1111/vco.12917
|
| 67 |
Riccardo Bazzoni, Angela Bentivegna. Role of Notch Signaling Pathway in Glioblastoma Pathogenesis. Cancers 2019; 11(3): 292 doi: 10.3390/cancers11030292
|
| 68 |
Alvaro G. Alvarado, Justin D. Lathia. Taking a Toll on Self-Renewal: TLR-Mediated Innate Immune Signaling in Stem Cells. Trends in Neurosciences 2016; 39(7): 463 doi: 10.1016/j.tins.2016.04.005
|
| 69 |
Zahra Asadzadeh, Behzad Mansoori, Ali Mohammadi, Marjan Aghajani, Khalil Haji‐Asgarzadeh, Elham Safarzadeh, Ahad Mokhtarzadeh, Pascal H. G. Duijf, Behzad Baradaran. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities. Journal of Cellular Physiology 2019; 234(7): 10002 doi: 10.1002/jcp.27885
|
| 70 |
Cobra Moradian, Fatemeh Rahbarizadeh. PE38-based gene therapy of HER2-positive breast cancer stem cells via VHH-redirected polyamidoamine dendrimers. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93972-5
|
| 71 |
Olga Troitskaya, Diana Novak, Anna Nushtaeva, Maria Savinkova, Mikhail Varlamov, Mikhail Ermakov, Vladimir Richter, Olga Koval. EGFR Transgene Stimulates Spontaneous Formation of MCF7 Breast Cancer Cells Spheroids with Partly Loss of HER3 Receptor. International Journal of Molecular Sciences 2021; 22(23): 12937 doi: 10.3390/ijms222312937
|
| 72 |
Kenta Kuramoto, Shuhei Suzuki, Hirotsugu Sakaki, Hiroyuki Takeda, Tomomi Sanomachi, Shizuka Seino, Yoshitaka Narita, Takamasa Kayama, Chifumi Kitanaka, Masashi Okada. Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction. FEBS Open Bio 2017; 7(6): 835 doi: 10.1002/2211-5463.12226
|
| 73 |
Hao-Yu Hsieh, Hsiao-Ching Chuang, Fang-Hsiu Shen, Kinjal Detroja, Ling-Wei Hsin, Ching-Shih Chen. Targeting breast cancer stem cells by novel HDAC3-selective inhibitors. European Journal of Medicinal Chemistry 2017; 140: 42 doi: 10.1016/j.ejmech.2017.08.069
|
| 74 |
Julia V. Nuzhina, Alexander A. Shtil, Artur Y. Prilepskii, Vladimir V. Vinogradov. Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines. Journal of Drug Delivery Science and Technology 2019; 54: 101282 doi: 10.1016/j.jddst.2019.101282
|
| 75 |
Saeedeh Keyvani-Ghamsari, Khatereh Khorsandi, Azhar Rasul, Muhammad Khatir Zaman. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01107-4
|
| 76 |
Farzaneh Ghaderi, Narges Jokar, Ali Gholamrezanezhad, Majid Assadi, Hojjat Ahmadzadehfar. Toward radiotheranostics in cancer stem cells: a promising initial step for tumour eradication. Clinical and Translational Imaging 2021; 9(6): 561 doi: 10.1007/s40336-021-00444-x
|
| 77 |
S. Talukdar, L. Emdad, S.K. Das, D. Sarkar, P.B. Fisher. . Advances in Cancer Research 2016; 131: 159 doi: 10.1016/bs.acr.2016.04.003
|
| 78 |
Javad Masoumi, Abdollah Jafarzadeh, Jalal Abdolalizadeh, Haroon Khan, Jeandet Philippe, Hamed Mirzaei, Hamid Reza Mirzaei. Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects. Acta Pharmaceutica Sinica B 2021; 11(7): 1721 doi: 10.1016/j.apsb.2020.12.015
|
| 79 |
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, Mahima Bansode, Kratika Khunteta, Priyanka Vijay Sonar, Ameya Hebale, Vaishnavi Salokhe, Birandra Kumar Sinha. Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review. Cancers 2024; 16(4): 680 doi: 10.3390/cancers16040680
|
| 80 |
Soudeep Dey, Yirivinti Hayagreeva Dinakar, Soundarya R, Vikas Jain, Rupshee Jain. Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; doi: 10.1007/s00210-024-03542-5
|
| 81 |
Fiorella Rossi, Hunter Noren, Richard Jove, Vladimir Beljanski, Karl-Henrik Grinnemo. Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Research & Therapy 2020; 11(1) doi: 10.1186/s13287-020-02018-6
|
| 82 |
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Seema Parte, Abhirup C. Are, Surinder K. Batra, Moorthy P. Ponnusamy. Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. Molecular Cancer 2022; 21(1) doi: 10.1186/s12943-022-01682-x
|
| 83 |
Jeong‐Ha Hwang, Junyong Yoon, Yong‐Hee Cho, Pu‐Hyeon Cha, Jong‐Chan Park, Kang‐Yell Choi. A mutant KRAS‐induced factor REG4 promotes cancer stem cell properties via Wnt/β‐catenin signaling. International Journal of Cancer 2020; 146(10): 2877 doi: 10.1002/ijc.32728
|
| 84 |
Ming Yin, Petros Grivas, Qi-En Wang, Amir Mortazavi, Hamid Emamekhoo, Sheldon L. Holder, Joseph J. Drabick, Michele Sue-Ann Woo, Sumanta Pal, Monali Vasekar, Edmund Folefac, Steven K. Clinton, Paul Monk, Monika Joshi. Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer. The Oncologist 2020; 25(8): 680 doi: 10.1634/theoncologist.2019-0851
|
| 85 |
Li Wang, Yanyang Liu, Yueling Zhou, Jiantao Wang, Li Tu, Zhen Sun, Xiujie Wang, Feng Luo. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1109-z
|
| 86 |
Khubaib Ali, Muhammad Nabeel, Fatima Mohsin, Mehwish Iqtedar, Muhammad Islam, Muhammad Fawad Rasool, Furqan K. Hashmi, Syed Ahmed Hussain, Hamid Saeed. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies. Medical Oncology 2024; 41(5) doi: 10.1007/s12032-024-02347-z
|
| 87 |
Luciana O. Almeida, Douglas M. Guimarães, Manoela D. Martins, Marco A.T. Martins, Kristy A. Warner, Jacques E. Nör, Rogerio M. Castilho, Cristiane H. Squarize. Unlocking the chromatin of adenoid cystic carcinomas using HDAC inhibitors sensitize cancer stem cells to cisplatin and induces tumor senescence. Stem Cell Research 2017; 21: 94 doi: 10.1016/j.scr.2017.04.003
|
| 88 |
Chiara Donini, Ramona Rotolo, Alessia Proment, Massimo Aglietta, Dario Sangiolo, Valeria Leuci. Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective. Cells 2021; 10(3): 543 doi: 10.3390/cells10030543
|
| 89 |
Daniela Predoi, Simona Liliana Iconaru, Mihai Valentin Predoi, Nicolas Buton, Christelle Megier, Mikael Motelica-Heino. Biocompatible Layers Obtained from Functionalized Iron Oxide Nanoparticles in Suspension. Coatings 2019; 9(12): 773 doi: 10.3390/coatings9120773
|
| 90 |
Ding Ren, Xiaoping Zhu, Ren Kong, Zhen Zhao, Jianting Sheng, Jiang Wang, Xiaoyun Xu, Jiyong Liu, Kemi Cui, Xiang H.-F. Zhang, Hong Zhao, Stephen T.C. Wong. Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer. Cancer Research 2018; 78(8): 2052 doi: 10.1158/0008-5472.CAN-17-2994
|
| 91 |
Jing Ma, Joseph Salamoun, Peter Wipf, Robert Edwards, Bennett Van Houten, Wei Qian. Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential. Oncotarget 2018; 9(5): 6042 doi: 10.18632/oncotarget.23679
|
| 92 |
Vivek Kumar, Parita Soni, Mohit Garg, Stephan Kamholz, Abhinav B. Chandra. Emerging Therapies in the Management of Advanced-Stage Gastric Cancer. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00404
|
| 93 |
Liuhang Xu, Ziqi Chen, Yangbin Wang, Yulin Li, Zhongyu Wang, Fangzhou Li, Xueyan Xi. Polyphyllin VII as a Potential Drug for Targeting Stemness in Hepatocellular Cancer via STAT3 Signaling. Current Cancer Drug Targets 2023; 23(4): 325 doi: 10.2174/1568009623666221024103834
|
| 94 |
Tsung-Jen Lin, Kuo-Chu Lai, An-Sheng Lee, Chien-Hsin Chang, Chiung-Lin Liu, Ching-Hu Chung. Novel Antrodia cinnamomea Extract Reduced Cancer Stem-Like Phenotype Changes and Resensitized KRAS-Mutant Colorectal Cancer via a MicroRNA-27a Pathway. Cancers 2019; 11(11): 1657 doi: 10.3390/cancers11111657
|
| 95 |
Xiaofan Lu, Caoyu Ji, Liyun Jiang, Yue Zhu, Yujie Zhou, Jialin Meng, Jun Gao, Tao Lu, Junmei Ye, Fangrong Yan. Tumour microenvironment‐based molecular profiling reveals ideal candidates for high‐grade serous ovarian cancer immunotherapy. Cell Proliferation 2021; 54(3) doi: 10.1111/cpr.12979
|
| 96 |
Lv Lv, Qiang Li, Shaohua Chen, Xuemei Zhang, Xuan Tao, Xianmin Tang, Shengtao Wang, Guosong Che, Yaqun Yu, Liang He. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L. Experimental Cell Research 2019; 385(1): 111597 doi: 10.1016/j.yexcr.2019.111597
|
| 97 |
Yi‐Nan Shen, Hai‐Guan He, Yang Shi, Jian Cao, Jian‐Yong Yuan, Zhou‐Chong Wang, Chun‐Feng Shi, Nan Zhu, Yong‐Peng Wei, Fang Liu, Jia‐Li Huang, Guang‐Shun Yang, Jun‐Hua Lu. Krüppel‐like factor 8 promotes cancer stem cell‐like traits in hepatocellular carcinoma through Wnt/β‐catenin signaling. Molecular Carcinogenesis 2017; 56(2): 751 doi: 10.1002/mc.22532
|
| 98 |
Yu-Hsiu Su, Tai-Yun Lin, Hung-Jen Liu, Chin-Kai Chuang. A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids. Oncotarget 2018; 9(29): 20490 doi: 10.18632/oncotarget.24960
|
| 99 |
Prarthna Yadav, Harshita Mishra, Manju Nagpal, Geeta Aggarwal. Expanding Opportunities in Treatment of Leukemia by Solid Lipid Nanoparticles. Letters in Drug Design & Discovery 2021; 18(3): 212 doi: 10.2174/1570180817999201001155508
|
| 100 |
Tsutomu Kanda, Takaaki Sugihara, Tomoaki Takata, Yukari Mae, Hidehito Kinoshita, Takuki Sakaguchi, Takashi Hasegawa, Hiroki Kurumi, Yuichiro Ikebuchi, Takashi Murakami, Hajime Isomoto. Low‑density lipoprotein receptor expression is involved in the beneficial effect of photodynamic therapy using talaporfin sodium on gastric cancer cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10004
|
| 101 |
Francesca De Santis, Sandra L. Romero-Cordoba, Lorenzo Castagnoli, Tatiana Volpari, Simona Faraci, Giovanni Fucà, Elda Tagliabue, Filippo De Braud, Serenella M. Pupa, Massimo Di Nicola. BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer. Cellular Oncology 2022; 45(2): 257 doi: 10.1007/s13402-022-00663-y
|
| 102 |
Maider Zabala, Neethan A. Lobo, Jane Antony, Luuk S. Heitink, Gunsagar S. Gulati, Jessica Lam, Natesh Parashurama, Kassandra Sanchez, Maddalena Adorno, Shaheen S. Sikandar, Angera H. Kuo, Dalong Qian, Tomer Kalisky, Sopheak Sim, Linus Li, Frederick M. Dirbas, George Somlo, Aaron Newman, Stephen R. Quake, Michael F. Clarke. LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis. Cell Stem Cell 2020; 27(2): 284 doi: 10.1016/j.stem.2020.06.017
|
| 103 |
Sunisa Thongsom, Satapat Racha, Korrakod Petsri, Zin Zin Ei, Kittichate Visuttijai, Sohsuke Moriue, Masashi Yokoya, Pithi Chanvorachote. Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-04016-6
|
| 104 |
Alina Molchadsky, Varda Rotter. p53 and its mutants on the slippery road from stemness to carcinogenesis. Carcinogenesis 2017; 38(4): 347 doi: 10.1093/carcin/bgw092
|
| 105 |
Timothy Henderson, Mingyi Chen, Morgan A. Darrow, Chin-Shang Li, Chi-Lu Chiu, Arta M. Monjazeb, William J. Murphy, Robert J. Canter. Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas. Journal of Surgical Research 2018; 223: 207 doi: 10.1016/j.jss.2017.11.016
|
| 106 |
Alisha Ramos, Samira Sadeghi, Hossein Tabatabaeian. Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them. International Journal of Molecular Sciences 2021; 22(17): 9451 doi: 10.3390/ijms22179451
|
| 107 |
Tung-Yu Tiong, Pei-Wei Weng, Chun-Hua Wang, Syahru Agung Setiawan, Vijesh Kumar Yadav, Narpati Wesa Pikatan, Iat-Hang Fong, Chi-Tai Yeh, Chia-Hung Hsu, Kuang-Tai Kuo. Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells. International Journal of Molecular Sciences 2022; 23(13): 7283 doi: 10.3390/ijms23137283
|
| 108 |
Evans K. Afenya, Rachid Ouifki, Suneel D. Mundle. Mathematical modeling of bone marrow – peripheral blood dynamics in the disease state based on current emerging paradigms, part II. Journal of Theoretical Biology 2019; 460: 37 doi: 10.1016/j.jtbi.2018.10.008
|
| 109 |
Md. Saiful Islam Roney, Song-Kyu Park. Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells. Archives of Pharmacal Research 2018; 41(4): 384 doi: 10.1007/s12272-018-1017-3
|
| 110 |
Korrakod Petsri, Masashi Yokoya, Satapat Racha, Sunisa Thongsom, Chorpaka Thepthanee, Bhurichaya Innets, Zin Zin Ei, Daiki Hotta, Hongbin Zou, Pithi Chanvorachote. Novel Synthetic Derivative of Renieramycin T Right-Half Analog Induces Apoptosis and Inhibits Cancer Stem Cells via Targeting the Akt Signal in Lung Cancer Cells. International Journal of Molecular Sciences 2023; 24(6): 5345 doi: 10.3390/ijms24065345
|
| 111 |
Valentina Masciale, Federico Banchelli, Giulia Grisendi, Anna Valeria Samarelli, Giulia Raineri, Tania Rossi, Michele Zanoni, Michela Cortesi, Sara Bandini, Paola Ulivi, Giovanni Martinelli, Franco Stella, Massimo Dominici, Beatrice Aramini. The molecular features of lung cancer stem cells (LCSCs) in dedifferentiation process-driven epigenetic alterations. Journal of Biological Chemistry 2024; : 107994 doi: 10.1016/j.jbc.2024.107994
|
| 112 |
Keihan Afshari, Karpal Singh Sohal. Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review. Cancer Control 2023; 30 doi: 10.1177/10732748231185003
|
| 113 |
Jennifer A. Waters, Carrie D. House. Overcoming Ovarian Cancer Chemoresistance. 2021; : 55 doi: 10.1016/B978-0-12-819840-7.00009-1
|
| 114 |
Santosh K. Misra, Zhe Wu, Fatemeh Ostadhossein, Mao Ye, Kingsley Boateng, Klaus Schulten, Emad Tajkhorshid, Dipanjan Pan. Pro-Nifuroxazide Self-Assembly Leads to Triggerable Nanomedicine for Anti-cancer Therapy. ACS Applied Materials & Interfaces 2019; 11(20): 18074 doi: 10.1021/acsami.9b01343
|
| 115 |
Ebrahim Razi, Mehran Radak, Maryam Mahjoubin-Tehran, Samaneh Talebi, Alimohammad Shafiee, Sarah Hajighadimi, Sanaz Moradizarmehri, Hossein Sharifi, Nousin Mousavi, Mostafa Sarvizadeh, Majid Nejati, Mohsen Taghizadeh, Faezeh Ghasemi. Cancer stem cells as therapeutic targets of pancreatic cancer. Fundamental & Clinical Pharmacology 2020; 34(2): 202 doi: 10.1111/fcp.12521
|
| 116 |
Priyanka Kaushik, Eepsita Priyadarshini, Kamla Rawat, Paulraj Rajamani, H.B. Bohidar. pH responsive doxorubucin loaded zein nanoparticle crosslinked pectin hydrogel as effective site-specific anticancer substrates. International Journal of Biological Macromolecules 2020; 152: 1027 doi: 10.1016/j.ijbiomac.2019.10.190
|
| 117 |
Monish Ram Makena, Alok Ranjan, Vani Thirumala, Arubala P Reddy. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(4): 165339 doi: 10.1016/j.bbadis.2018.11.015
|
| 118 |
Natasha Hodgkinson, Cherie A Kruger, Heidi Abrahamse. Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells. Tumor Biology 2017; 39(10): 101042831773469 doi: 10.1177/1010428317734691
|
| 119 |
Ji Young Park, Ae Lee Jeong, Hyun Jeong Joo, Sora Han, So-Hyun Kim, Hye-Youn Kim, Jong-Seok Lim, Myeong-Sok Lee, Hyung-Kyoon Choi, Young Yang. Development of suspension cell culture model to mimic circulating tumor cells. Oncotarget 2018; 9(1): 622 doi: 10.18632/oncotarget.23079
|
| 120 |
Florian Cabillic, Anne Corlu. Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma. Gastroenterology 2016; 151(4): 607 doi: 10.1053/j.gastro.2016.06.052
|
| 121 |
Rashi Arora, Apoorva Uboveja, Rama Kadamb. Cancer Epigenetics and Nanomedicine. 2024; : 93 doi: 10.1016/B978-0-443-13209-4.00018-0
|
| 122 |
|
| 123 |
Raghupathy Vengoji, Moorthy P Ponnusamy, Satyanarayana Rachagani, Sidharth Mahapatra, Surinder K Batra, Nicole Shonka, Muzafar A Macha. Novel therapies hijack the blood–brain barrier to eradicate glioblastoma cancer stem cells. Carcinogenesis 2019; 40(1): 2 doi: 10.1093/carcin/bgy171
|
| 124 |
Mengyao Sun, Yang Bai, Song Zhao, Xiyu Liu, Yongsheng Gao, Lei Wang, Bin Liu, Dashi Ma, Chunye Ma. Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer. Oncotarget 2018; 9(17): 13462 doi: 10.18632/oncotarget.24008
|
| 125 |
M. E. El-Houseini, A. Ismail, A. A. Abdelaal, A. H. El-Habashy, Z. F. Abdallah, M. Z. Mohamed, M. El-Hadidi, W. C. S. Cho, H. Ahmed, T. A. Al-Shafie. Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study. Biochemistry (Moscow) 2019; 84(8): 941 doi: 10.1134/S0006297919080108
|
| 126 |
Qi Tang, Dan Yin, Yao Wang, Wenxuan Du, Yuhan Qin, Anni Ding, Hanmei Li. Cancer Stem Cells and Combination Therapies to Eradicate Them. Current Pharmaceutical Design 2020; 26(17): 1994 doi: 10.2174/1381612826666200406083756
|
| 127 |
Mohd Anees, Priya Gupta, Harshdeep Kaur, Surender Kharbanda, Harpal Singh. Concomitant Delivery of Pirarubicin and Salinomycin Synergistically Enhanced the Efficacy of Cancer Therapy and Reduced the Risk of Cancer Relapse. AAPS PharmSciTech 2024; 25(7) doi: 10.1208/s12249-024-02918-3
|
| 128 |
Diana Rafael, Petra Gener, Fernanda Andrade, Joaquin Seras-Franzoso, Sara Montero, Yolanda Fernández, Manuel Hidalgo, Diego Arango, Joan Sayós, Helena F. Florindo, Ibane Abasolo, Simó Schwartz, Mafalda Videira. AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells. Drug Delivery 2018; 25(1): 961 doi: 10.1080/10717544.2018.1461276
|
| 129 |
David H. Margarit, Lilia Romanelli, Alejandro J. Fendrik. A 3D Cellular Automaton for Cell Differentiation in a Solid Tumor with Plasticity. Biophysical Reviews and Letters 2018; 13(01): 19 doi: 10.1142/S1793048018500029
|
| 130 |
Valentina Pozzi, Eleonora Salvolini, Guendalina Lucarini, Alessia Salvucci, Roberto Campagna, Corrado Rubini, Davide Sartini, Monica Emanuelli. Cancer stem cell enrichment is associated with enhancement of nicotinamide N‐methyltransferase expression. IUBMB Life 2020; 72(7): 1415 doi: 10.1002/iub.2265
|
| 131 |
Mohd Anees, Neha Mehrotra, Sachchidanand Tiwari, Dinesh Kumar, Surender Kharbanda, Harpal Singh. Polylactic acid based biodegradable hybrid block copolymeric nanoparticle mediated co-delivery of salinomycin and doxorubicin for cancer therapy. International Journal of Pharmaceutics 2023; 635: 122779 doi: 10.1016/j.ijpharm.2023.122779
|
| 132 |
Wanyin Chen, Jihu Dong, Jacques Haiech, Marie-Claude Kilhoffer, Maria Zeniou, Javier Garcia-Castro. Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/1740936
|
| 133 |
Annamaria Antona, Giovanni Leo, Francesco Favero, Marco Varalda, Jacopo Venetucci, Stefania Faletti, Matilde Todaro, Eleonora Mazzucco, Enrica Soligo, Chiara Saglietti, Giorgio Stassi, Marcello Manfredi, Giuliana Pelicci, Davide Corà, Guido Valente, Daniela Capello. Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01502-1
|
| 134 |
Shimen Gevargiz Sangar, Negar Agahi, Alireza Azizi, Nikoo Sadat Hasheminezhad, Emad Ghannad, Parmida Nafei, Mohammad Moeen Babayi. In Vivo Stem Cell Discoveries: Promising Implications in Cancer Therapy. Journal of Lab Animal Research 2023; 2(5): 23 doi: 10.58803/jlar.v2i5.27
|
| 135 |
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera, Brigitte M. Pützer. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Seminars in Cancer Biology 2018; 53: 90 doi: 10.1016/j.semcancer.2018.06.006
|
| 136 |
Yu Hua Quan, Ji-Young Lim, Byeong Hyeon Choi, Yeonho Choi, Young Ho Choi, Ji-Ho Park, Hyun Koo Kim. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells. Cancer Chemotherapy and Pharmacology 2019; 83(3): 399 doi: 10.1007/s00280-018-3737-y
|
| 137 |
Amani Yehya, Joe Youssef, Sana Hachem, Jana Ismael, Wassim Abou-Kheir. Tissue-specific cancer stem/progenitor cells: Therapeutic implications. World Journal of Stem Cells 2023; 15(5): 323-341 doi: 10.4252/wjsc.v15.i5.323
Abstract(407) |
Core Tip(389) |
Full Article(HTML)(1672)
|
Full Article (PDF)-1342K(136)
|
Full Article (Word)-646K(50)
|
Audio-875K(2)
|
Peer-Review Report-199K(59)
|
Answering Reviewers-265K(57)
|
Times Cited (0)
|
Total Visits (4616)
|
Open
|
| 138 |
Alessandra Loda, Francesco Semeraro, Silvia Parolini, Roberto Ronca, Sara Rezzola. Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(3): 189104 doi: 10.1016/j.bbcan.2024.189104
|
| 139 |
Sara Pączek, Monika Zajkowska, Barbara Mroczko. Pigment Epithelial-Derived Factor in Pancreatic and Liver Cancers—From Inflammation to Cancer. Biomedicines 2024; 12(10): 2260 doi: 10.3390/biomedicines12102260
|
| 140 |
Xiaolan Jiang, Herma Renkema, Jan Smeitink, Julien Beyrath, Gianpaolo Papaccio. Sonlicromanol’s active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth. PLOS ONE 2021; 16(7): e0254315 doi: 10.1371/journal.pone.0254315
|
| 141 |
Sara Sadat Aghamiri, Rada Amin. Cancer Stem Cell Metastatic Checkpoints and Glycosylation Patterns: Implications for Therapeutic Strategies. Kinases and Phosphatases 2024; 2(2): 151 doi: 10.3390/kinasesphosphatases2020009
|
| 142 |
Lan Thi Hanh Phi, Ita Novita Sari, Ying-Gui Yang, Sang-Hyun Lee, Nayoung Jun, Kwang Seock Kim, Yun Kyung Lee, Hyog Young Kwon. Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment. Stem Cells International 2018; 2018: 1 doi: 10.1155/2018/5416923
|
| 143 |
Shomereeta Roy, Souvick Roy, Madhabananda Kar, Swatishree Padhi, Arka Saha, Kumari Anuja, Birendranath Banerjee. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma. Journal of Oral Pathology & Medicine 2018; 47(5): 492 doi: 10.1111/jop.12707
|
| 144 |
Sukru Ozturk, Cansu Gorgun, Sevtap Gokalp, Seda Vatansever, Aylin Sendemir. Development and characterization of cancer stem cell‐based tumoroids as an osteosarcoma model. Biotechnology and Bioengineering 2020; 117(8): 2527 doi: 10.1002/bit.27381
|
| 145 |
Farnaz Hajizadeh, Isobel Okoye, Maryam Esmaily, Mitra Ghasemi Chaleshtari, Ali Masjedi, Gholamreza Azizi, Mahzad Irandoust, Ghasem Ghalamfarsa, Farhad Jadidi-Niaragh. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sciences 2019; 237: 116952 doi: 10.1016/j.lfs.2019.116952
|
| 146 |
Brigitte M. Pützer, Manish Solanki, Ottmar Herchenröder. Advances in cancer stem cell targeting: How to strike the evil at its root. Advanced Drug Delivery Reviews 2017; 120: 89 doi: 10.1016/j.addr.2017.07.013
|
| 147 |
Selcen ARI. Meme Kanser Kök Hücrelerinde Notch Sinyal Yolağının İnhibisyonunda Güncel Yaklaşımlar. Marmara Fen Bilimleri Dergisi 2018; 30(1): 94 doi: 10.7240/marufbd.336015
|
| 148 |
Suji Han, Hyemi Shin, Jin-Ku Lee, Zhaoqi Liu, Raul Rabadan, Jeongwu Lee, Jihye Shin, Cheolju Lee, Heekyoung Yang, Donggeon Kim, Sung Heon Kim, Jooyeon Kim, Jeong-Woo Oh, Doo-Sik Kong, Jung-Il Lee, Ho Jun Seol, Jung Won Choi, Hyun Ju Kang, Do-Hyun Nam. Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target. Experimental & Molecular Medicine 2019; 51(12): 1 doi: 10.1038/s12276-019-0351-y
|
| 149 |
Hisashi Tamada, Takeshi Uehara, Takahiro Yoshizawa, Mai Iwaya, Shiho Asaka, Tomoyuki Nakajima, Masato Kamakura, Hiroyoshi Ota. Exploring LGR5 as a prognostic marker of extrahepatic cholangiocarcinoma: insights from expression analysis and clinical correlations. Diagnostic Pathology 2024; 19(1) doi: 10.1186/s13000-024-01537-7
|
| 150 |
Aprilia MAHARANI, Keisuke AOSHIMA, Shinichi ONISHI, Kevin Christian Montecillo GULAY, Atsushi KOBAYASHI, Takashi KIMURA. Cellular atypia is negatively correlated with immunohistochemical reactivity of CD31 and vWF expression levels in canine hemangiosarcoma. Journal of Veterinary Medical Science 2018; 80(2): 213 doi: 10.1292/jvms.17-0561
|
| 151 |
Pritish Nilendu, Ajay Kumar, Azad Kumar, Jayanta K. Pal, Nilesh Kumar Sharma. Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack. International Journal of Cancer 2018; 142(1): 7 doi: 10.1002/ijc.30898
|
| 152 |
Nalinrat Petpiroon, Narumol Bhummaphan, Rapeepun Soonnarong, Wipa Chantarawong, Tosapol Maluangnont, Varisa Pongrakhananon, Pithi Chanvorachote. Ti0.8O2Nanosheets Inhibit Lung Cancer Stem Cells by Inducing Production of Superoxide Anion. Molecular Pharmacology 2019; 95(4): 418 doi: 10.1124/mol.118.114447
|
| 153 |
Guadalupe Dominguez‑Gomez, Alma Chavez‑Blanco, Jose Medina‑Franco, Fernanda Saldivar‑Gonzalez, Ytzel Flores‑Torrontegui, Mandy Juarez, Jos� D�az‑Ch�vez, Aurora Gonzalez‑Fierro, Alfonso Due�as‑Gonz�lez. Ivermectin as an inhibitor of cancer stem‑like cells. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8231
|
| 154 |
Tanu Sharma, Chandi C. Mandal. Cancer Stem Cells: New Horizons in Cancer Therapies. 2020; : 241 doi: 10.1007/978-981-15-5120-8_14
|
| 155 |
Dingcheng Gao, Vivek Mittal, Yi Ban, Ana Rita Lourenco, Shira Yomtoubian, Sharrell Lee. Metastatic tumor cells – genotypes and phenotypes. Frontiers in Biology 2018; 13(4): 277 doi: 10.1007/s11515-018-1513-3
|
| 156 |
Zahra Ghanbari Movahed, Mohsen Rastegari-Pouyani, Mohammad hossein Mohammadi, Kamran Mansouri. Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?. Biomedicine & Pharmacotherapy 2019; 112: 108690 doi: 10.1016/j.biopha.2019.108690
|
| 157 |
Rocío G. Sampayo, Mina J. Bissell. . Advances in Cancer Research 2019; 144: 315 doi: 10.1016/bs.acr.2019.03.010
|
| 158 |
Sahdeo Prasad, Sharavan Ramachandran, Nehal Gupta, Itishree Kaushik, Sanjay K. Srivastava. Cancer cells stemness: A doorstep to targeted therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(4): 165424 doi: 10.1016/j.bbadis.2019.02.019
|
| 159 |
Matthew Martin, Antja-Voy Hartley, Jiamin Jin, Mengyao Sun, Tao Lu. Adenosine Triphosphate in Health and Disease. 2019; doi: 10.5772/intechopen.83650
|
| 160 |
Maria Letizia Ciavatta, Florence Lefranc, Marianna Carbone, Ernesto Mollo, Margherita Gavagnin, Tania Betancourt, Ramesh Dasari, Alexander Kornienko, Robert Kiss. Marine Mollusk‐Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. Medicinal Research Reviews 2017; 37(4): 702 doi: 10.1002/med.21423
|
| 161 |
Keisuke Aoshima, Yuki Fukui, Kevin Christian Montecillo Gulay, Ochbayar Erdemsurakh, Atsuya Morita, Atsushi Kobayashi, Takashi Kimura. Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells. BMC Veterinary Research 2018; 14(1) doi: 10.1186/s12917-018-1624-8
|
| 162 |
Eunice Yuen-Ting Lau, Nicole Pui-Yu Ho, Terence Kin-Wah Lee. Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications. Stem Cells International 2017; 2017: 1 doi: 10.1155/2017/3714190
|
| 163 |
Dai Kamamoto, Isako Saga, Kentaro Ohara, Kazunari Yoshida, Hikaru Sasaki. Association Between CD133, CD44, and Nestin Expression and Prognostic Factors in High-Grade Meningioma. World Neurosurgery 2019; 124: e188 doi: 10.1016/j.wneu.2018.12.067
|
| 164 |
Theresa Relation, Massimo Dominici, Edwin M. Horwitz. Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells. Stem Cells 2017; 35(5): 1123 doi: 10.1002/stem.2596
|
| 165 |
Sowmya Vishnubhakthula, Ravinder Elupula, Esteban F. Durán-Lara. Recent Advances in Hydrogel-Based Drug Delivery for Melanoma Cancer Therapy: A Mini Review. Journal of Drug Delivery 2017; 2017: 1 doi: 10.1155/2017/7275985
|
| 166 |
Patrycja Czerwińska, Sylwia Mazurek, Maciej Wiznerowicz. Application of induced pluripotency in cancer studies. Reports of Practical Oncology & Radiotherapy 2018; 23(3): 207 doi: 10.1016/j.rpor.2018.04.005
|
| 167 |
Saminur Hoque, Rajib Dhar, Rishav Kar, Sayantanee Mukherjee, Dattatreya Mukherjee, Nobendu Mukerjee, Sagnik Nag, Namrata Tomar, Saurav Mallik. Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance. Biomarkers 2023; 28(2): 139 doi: 10.1080/1354750X.2022.2157875
|
| 168 |
Akshatha E. Nagarkatte, Prathibha Ranganathan. Epigenetic Therapy for Cancer Stem Cells. Resonance 2023; 28(5): 697 doi: 10.1007/s12045-023-1600-x
|
| 169 |
Elizabeth Wei-Chia Luo, Meng-Lin Liao, Chung-Liang Chien, Tomasz Boczek. Neural differentiation of glioblastoma cell lines via a herpes simplex virus thymidine kinase/ganciclovir system driven by a glial fibrillary acidic protein promoter. PLOS ONE 2021; 16(8): e0253008 doi: 10.1371/journal.pone.0253008
|
| 170 |
Shin-Yi Chung, Yen-Hsi Chen, Pei-Rong Lin, Ta-Chung Chao, Jung-Chen Su, Chung-Wai Shiau, Yeu Su. Two novel SHP-1 agonists, SC-43 and SC-78, are more potent than regorafenib in suppressing the in vitro stemness of human colorectal cancer cells. Cell Death Discovery 2018; 4(1) doi: 10.1038/s41420-018-0084-z
|
| 171 |
Mahrokh Marzi, Mahsa Rostami Chijan, Elham Zarenezhad. Hydrogels as promising therapeutic strategy for the treatment of skin cancer. Journal of Molecular Structure 2022; 1262: 133014 doi: 10.1016/j.molstruc.2022.133014
|
| 172 |
Lien-Hung Huang, Shao-Chun Wu, Yueh-Wei Liu, Hang-Tsung Liu, Peng-Chen Chien, Hui-Ping Lin, Chia-Jung Wu, Ting-Min Hsieh, Ching-Hua Hsieh. Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(22): 11969 doi: 10.3390/ijms252211969
|
| 173 |
Agata Raniszewska, Małgorzata Polubiec-Kownacka, Elzbieta Rutkowska, Joanna Domagala-Kulawik. PD-L1 Expression on Lung Cancer Stem Cells in Metastatic Lymph Nodes Aspirates. Stem Cell Reviews and Reports 2019; 15(2): 324 doi: 10.1007/s12015-018-9860-7
|
| 174 |
Jang Mi Han, Yu Jin Kim, Hye Jin Jung. Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells. Cancers 2022; 14(5): 1315 doi: 10.3390/cancers14051315
|
| 175 |
Peng-Chan Lin, Hao-Yu Hsieh, Po-Chen Chu, Ching S. Chen. Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells. International Journal of Molecular Sciences 2018; 19(7): 1939 doi: 10.3390/ijms19071939
|
| 176 |
Gérald J. Prud’homme, Yelena Glinka, Pratiek N. Matkar, Howard Leong-Poi. The Neuropilins: Role and Function in Health and Disease. 2017; : 187 doi: 10.1007/978-3-319-48824-0_11
|
| 177 |
Darinthip Suksamai, Satapat Racha, Nicharat Sriratanasak, Chatchai Chaotham, Kanokpol Aphicho, Aye Chan Khine Lin, Chaisak Chansriniyom, Khanit Suwanborirux, Supakarn Chamni, Pithi Chanvorachote. 5-O-(N-Boc-l-Alanine)-Renieramycin T Induces Cancer Stem Cell Apoptosis via Targeting Akt Signaling. Marine Drugs 2022; 20(4): 235 doi: 10.3390/md20040235
|
| 178 |
Mariacarmela Santarpia, Marta Aliprandi, Calogera Claudia Spagnolo, Amir Avan, Rafael Rosell, Paolo Andrea Zucali, Elisa Giovannetti. NOTCH and PTP4A3 alterations emerge as novel predictive biomarkers and potential therapeutic targets in pleural mesothelioma. Lung Cancer 2024; 198: 108024 doi: 10.1016/j.lungcan.2024.108024
|